Investing in Tomorrow’s Food: The Global Plant-Based and Alt-Protein Marketplace

This event brings together life sciences leaders to discuss the realities of navigating today’s pharmaceutical projects, from early planning and design through startup, validation, and commercial readiness.

Panelists will discuss owner-side perspectives on project execution, operational readiness, collaboration, and the evolving challenges shaping modern life sciences facilities and manufacturing environments.

​Featured Panelists: 

The inaugural Women's Health Multidisciplinary Research Symposium, to be held at UNC, will foster interdisciplinary connections, collaboration, and knowledge sharing among trainees and faculty passionate about women’s health research.  

This symposium is hosted by the Women’s Health Multidisciplinary Consortium (WHMC) and the Department of Pathology and Laboratory Medicine and supported by the Center for Women’s Health Research and the School of Medicine’s Department of Obstetrics & Gynecology.  

United Therapeutics Corporation, a public benefit corporation with co-headquarters in Research Triangle Park, has received U.S. Food and Drug Administration (FDA) clearance under the company’s Investigational New Drug application to proceed with a clinical study of its investigational UHeart xenoheart derived from a pig.